A study of 783 patients treated with CAR T cell therapy found no evidence that the therapy itself caused secondary cancers.

Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the therapy itself caused any type of secondary cancer in the modified T cells, ...

Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk.

Researchers have developed a groundbreaking AI model that identifies tumor-fighting immune cells, enhancing cancer ...

Liposuction and plastic surgery aren't often mentioned in the same breath as cancer. But they are the inspiration for a new approach to treating cancer that uses engineered fat cells to deprive tumors ...

A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...

Once inside T cells, the cancer-derived mitochondria gradually ... also showed resistance to immune checkpoint inhibitors, a type of immunotherapy. By identifying mitochondrial transfer as a ...